| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |